Briefing
The Daily Briefing — 11 June 2026
Federal marijuana trafficking prosecutions in US fall to historic low New data from the United States shows that federal law enforcement officials charged fewer than 400 people with marijuana
Research
Clinical trials, cannabinoid science, and the evidence shaping policy.
Briefing
The Daily Briefing — 5 June 2026
Alabama patients finally gain access to authorised medical cannabis after years of delays Patients in Alabama can now legally purchase authorised medical cannabis products, following years of
Briefing
The Daily Briefing — 4 June 2026
Kentucky governor signs executive order expanding medical cannabis access Governor Andy Beshear has issued an emergency executive order expanding access to medical cannabis in Kentucky. The order,
Briefing
The Daily Briefing — 3 June 2026
Kentucky Governor expands medical cannabis access via executive order Governor Andy Beshear has issued an executive order expanding medical cannabis access in Kentucky. The emergency regulation is
Briefing
The Daily Briefing — 2 June 2026
Global cancer workforce shortage raises concerns for patient access to care A new report from researchers published by The Guardian warns that the world faces a cancer workforce crisis, with a
Briefing
The Daily Briefing — 31 May 2026
New analysis finds opioid overdoses decline after cannabis legalisation A fresh analysis published this week by NORML has added to the growing body of evidence that legal cannabis access is
.webp)
Briefing
The Daily Briefing — 30 May 2026
Analysis finds opioid overdose rates decline after cannabis legalisation A new analysis published this week adds to the growing body of evidence linking legal cannabis access to reductions in
Briefing
The Daily Briefing — 29 May 2026
Pew Poll finds majority of Americans now oppose cannabis prohibition A new survey from the Pew Research Centre has found that support for ending cannabis prohibition continues to grow among the
Briefing
The Daily Briefing — 28 May 2026
Pew Poll Shows Strong Public Support for Ending Marijuana Prohibition in US A new poll from the Pew Research Center has found that marijuana prohibition is increasingly unpopular among Americans. The
Briefing
The Daily Briefing — 27 May 2026
Pew poll finds broad US public support for ending cannabis prohibition A new survey from the Pew Research Center has found that marijuana prohibition is increasingly unpopular among American voters.
.webp)
Briefing
The Daily Briefing — 26 May 2026
NORML seeks representation at DEA rescheduling hearing The National Organisation for the Reform of Marijuana Laws (NORML) has formally requested a seat at the upcoming Drug Enforcement Administration
Briefing
The Daily Briefing — 25 May 2026
NORML calls for renewed support in fight for cannabis justice The US advocacy organisation NORML has issued a public appeal for continued support, arguing that the fight for "justice, equity, and
Briefing
The Daily Briefing — 24 May 2026
Amber heat health alerts issued for UK bank holiday weekend The UK Health Security Agency has issued amber heat health alerts for the bank holiday weekend, with forecasters predicting record-breaking
Research
Key Cannabinoid Research Studies to Watch in 2026
From pain management to mental health, the clinical research pipeline for cannabinoid medicines is more active than ever. Here are the studies to watch.
Research
CBD for Anxiety: What the Latest Clinical Trials Tell Us
New clinical trials are providing clearer evidence on CBD's potential for anxiety disorders. Here's what the science says in May 2026.
Research
THC for Chronic Pain: New Evidence Strengthens the Case
A major new meta-analysis provides some of the strongest evidence yet for THC-based treatments in chronic pain management.
Research
Beyond THC and CBD: The Emerging Science of Terpenes
Terpenes — the aromatic compounds in cannabis — are emerging as a key area of research with potential therapeutic applications.
USA
FDA Unveils Long-Awaited CBD Regulatory Framework, Sparking Industry Debate
FDA releases March 2026 draft guidance on hemp-derived CBD, proposing a 20 mg daily cap and strict labelling rules for a $4B+ market.